Paper20680652
OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users.
Becker ML and 5 others. Neurogenetics, 2011. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Papers, record 20680652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20680652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiparkinson Agents | Major topic |
| Organic Cation Transporter 1 | Major topic |
| Parkinson Disease | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Aged | |
| Aged, 80 and over | |
| Alleles | |
| Cohort Studies | |
| Female | |
| Humans | |
| Levodopa | |
| Male | |
| Pharmacogenetics | |
| Proportional Hazards Models | |
| Survival Analysis |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11191835 | Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. | Naunyn Schmiedebergs Arch Pharmacol | 2001 | https://conductscience.org/library/papers/11191835 | PubMed |
| 2 | 19728115 | The Rotterdam Study: 2010 objectives and design update. | Eur J Epidemiol | 2009 | https://conductscience.org/library/papers/19728115 | PubMed |
| 3 | 12438515 | The cation transporters rOCT1 and rOCT2 interact with bicarbonate but play only a minor role for amantadine uptake into rat renal proximal tubules. | J Pharmacol Exp Ther | 2002 | https://conductscience.org/library/papers/12438515 | PubMed |
| 4 | 14576340 | Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). | J Pharmacol Exp Ther | 2004 | https://conductscience.org/library/papers/14576340 | PubMed |
| 5 | 17307202 | Blood-brain barrier transport of pramipexole, a dopamine D2 agonist. | Life Sci | 2007 | https://conductscience.org/library/papers/17307202 | PubMed |
| 6 | 14685227 | The International HapMap Project. | Nature | 2003 | https://conductscience.org/library/papers/14685227 | PubMed |
| 7 | 9204539 | Opossum kidney cells take up L-DOPA through an organic cation potential-dependent and proton-independent transporter. | Cell Biol Int | 1997 | https://conductscience.org/library/papers/9204539 | PubMed |
| 8 | 8762102 | Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. | Br J Pharmacol | 1996 | https://conductscience.org/library/papers/8762102 | PubMed |
| 9 | 17473959 | Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. | Pharm Res | 2007 | https://conductscience.org/library/papers/17473959 | PubMed |
| 10 | 9776363 | Catecholamine transport by the organic cation transporter type 1 (OCT1). | Br J Pharmacol | 1998 | https://conductscience.org/library/papers/9776363 | PubMed |
| 11 | 19381165 | Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. | Pharmacogenomics J | 2009 | https://conductscience.org/library/papers/19381165 | PubMed |
| 12 | 15640376 | Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. | Drug Metab Dispos | 2005 | https://conductscience.org/library/papers/15640376 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40201683 | Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40201683 | PubMed |
| 39403148 | Longitudinal assessment of SNPs rs72552763 and rs622342 in SLC22A1 over HbA1c control among Mexican-Mestizo diabetic type 2 patients. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39403148 | PubMed |
| 36582064 | Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease. | Curr Neuropharmacol | 2023 | https://conductscience.org/library/papers/36582064 | PubMed |
| 36297437 | Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36297437 | PubMed |
| 35754508 | High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35754508 | PubMed |
| 35336971 | Dengue Virus Replication Is Associated with Catecholamine Biosynthesis and Metabolism in Hepatocytes. | Viruses | 2022 | https://conductscience.org/library/papers/35336971 | PubMed |
| 34834946 | Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway. | Viruses | 2021 | https://conductscience.org/library/papers/34834946 | PubMed |
| 34495395 | Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/34495395 | PubMed |
| 34281267 | A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics? | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34281267 | PubMed |
| 34025422 | Effects of a Common Eight Base Pairs Duplication at the Exon 7-Intron 7 Junction on Splicing, Expression, and Function of OCT1. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34025422 | PubMed |
| 33674914 | Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/33674914 | PubMed |
| 31231590 | The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes. | J Drug Assess | 2019 | https://conductscience.org/library/papers/31231590 | PubMed |
| 30745869 | Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/30745869 | PubMed |
| 30363349 | Pharmacogenetics of Parkinson's Disease in Clinical Practice. | Mov Disord Clin Pract | 2017 | https://conductscience.org/library/papers/30363349 | PubMed |
| 29659532 | Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition. | J Pers Med | 2018 | https://conductscience.org/library/papers/29659532 | PubMed |
| 29356624 | From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms. | OMICS | 2018 | https://conductscience.org/library/papers/29356624 | PubMed |
| 29305687 | Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies. | Neuromolecular Med | 2018 | https://conductscience.org/library/papers/29305687 | PubMed |
| 27447939 | Transporters as Drug Targets in Neurological Diseases. | Clin Pharmacol Ther | 2016 | https://conductscience.org/library/papers/27447939 | PubMed |
| 26526073 | Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions. | Pharmacogenomics J | 2015 | https://conductscience.org/library/papers/26526073 | PubMed |
| 25455070 | The role of glia in stress: polyamines and brain disorders. | Psychiatr Clin North Am | 2014 | https://conductscience.org/library/papers/25455070 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SLC22A1 | 6580 | PubTator's text mining | https://conductscience.org/library/genes/6580 | NCBI Gene |
| SLC22A2 | 6582 | PubTator's text mining | https://conductscience.org/library/genes/6582 | NCBI Gene |
| SLC22A3 | 6581 | PubTator's text mining | https://conductscience.org/library/genes/6581 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20680652
GET https://conductscience.org/api/papers/v1/20680652/cited_by?page=2